Kumar P
Recognizing Lean Liver Disease in Clinical Practice Clinicians should consider metabolic liver disease in patients who present with: Normal BMI but central adiposity (increased waist circumference) Mildly elevated liver enzymes without a clear cause Dyslipidemia or insulin resistance features Fatty liver on incidental imaging Routine use of noninvasive tests such as FIB4, ELF score, or transient elastography can help stratify risk and guide hepatology referrals
When you are already dealing with the gastrointestinal effects of a GLP-1 medication, choosing the right form matters enormously
For people whose primary concern is metabolic health rather than maximum weight loss, dulaglutide deserves consideration
At Week 26, the primary HbA1c endpoint was missing for 5.6%, 8.6% and 8.6% of patients randomized to placebo, semaglutide tablets 7 mg and semaglutide tablets14 mg, respectively
Because the body spews free radicals when it uses oxygen, the brain is awash in rogue molecules